Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciné-RIF
NCT07788404Recruiting
- Sponsor
- Groupe Hospitalier Diaconesses Croix Saint-Simon
- Start
- Jun 2023
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Open-label, single-arm trial of rifampicin in Staphylococcal osteoarticular infection, sponsored by Groupe Hospitalier Diaconesses Croix Saint-Simon. Primary endpoints: Area Under the Plasma Concentration-Time Curve of Rifampicin, Peak Plasma Concentration of Rifampicin and 2 more. Started Jun 2023; status: recruiting.
02
Drugs
rifampicin
03
Conditions
Staphylococcal osteoarticular infection
Beyond the preview
Go deeper on NCT07788404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07788404.